The following financial statements are taken from the records of Organo Inc. a) Use horizontal analysis techniques to compare the changes between 2020 and 2019 balance sheet items. Do not enter dollar signs or commas in the input boxes. Use the negative sign for negative values. Round all percentages to 2 decimal places. Organo Inc. Balance Sheet As at November 30 2020 2019 $ Change % Change Current Assets Cash $314.900 $321,400 $ % Accounts Receivable $209,300 $180,500 $ % Merchandise Inventory $428,400 $402,800 $ % Short-Term Investments $83,400 $97.900 $ % Total Current Assets $1,036,000 $1,002,600 $ % Long-Term Assets $444,600 $328,100 $ % Total Assets $1,480,600 $1,330,700 $ % Current Liabilities $268,400 $ 237,100 $ % Long-Term Liabilities $134,100 $102,700 $ % Total Liabilities $402.500 $339,800 $ % Shareholders' Equity $1,078,100 $990,900 $ % Total Liabilities and Equity $1,480,600 $1,330,700 $ % b) Perform a vertical analysis of the income statement for 2020, stating all income statement items as a percentage of net sales. Organo Inc. Income Statement For the Year Ended December 31 2020 Sales $681,000 % Cost of Goods Sold $374,550 % Gross Profit $306,450 % Operating Expenses Advertising Expense $4,800 % Utilities Expense $8,300 % Rent Expense $4,100 % Salaries and Wages Expense $49,700 % Depreciation Expense $34,300 de Interest Expense $7,600 % Total Expenses $108,800 % Income Before Income Tax $ 197,650 Income Tax Expense $59,295 de Net Income $138,355 % Check